Abstract:Ataxia telangiectasia-mutated (ATM) protein kinase, a key player in cellular integrity regulation, is known for its role in DNA damage response. This study investigates the broader impact of ATM on cellular processes and potential clinical manifestations arising from mutations, aiming to expand our understanding of ATM's diverse functions beyond conventional roles. The research employs a comprehensive set of computational techniques for a thorough analysis of ATM mutations. The mutation data are curated from dbSNP and HuVarBase databases. A meticulous assessment is conducted, considering factors such as deleterious effects, protein stability, oncogenic potential, and biophysical characteristics of the identified mutations. Conservation analysis, utilizing diverse computational tools, provides insights into the evolutionary significance of these mutations. Molecular docking and dynamic simulation analyses are carried out for selected mutations, investigating their interactions with Y2080D, AZD0156, and quercetin inhibitors to gauge potential therapeutic implications. Among the 419 mutations scrutinized, five (V1913C, Y2080D, L2656P, C2770G, and C2930G) are identified as both disease causing and protein destabilizing. The study reveals the oncogenic potential of these mutations, supported by findings from the COSMIC database. Notably, Y2080D is associated with haematopoietic and lymphoid cancers, while C2770G shows a correlation with squamous cell carcinomas. Molecular docking and dynamic simulation analyses highlight strong binding affinities of quercetin for Y2080D and AZD0156 for C2770G, suggesting potential therapeutic options. In summary, this computational analysis provides a comprehensive understanding of ATM mutations, revealing their potential implications in cellular integrity and cancer development. The study underscores the significance of Y2080D and C2770G mutations, offering valuable insights for future precision medicine targeting-specific ATM. Despite informative computational analyses, a significant research gap exists, necessitating essential in vitro and in vivo studies to validate the predicted effects of ATM mutations on protein structure and function.

Implication of Ataxia-Telangiectasia-mutated Kinase in Epithelium-Mesenchyme Transition

Ataxia-Telangiectasia Mutated (ATM) gene signaling pathways in human cancers and their therapeutic implications

Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies

ATM and Telomere Instability

Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation

Dual Roles of ATM in the Cellular Response to Radiation and in Cell Growth Control.

ATM modulates nuclear mechanics by regulating lamin A levels

Activation of the Atm-Snail Pathway Promotes Breast Cancer Metastasis

ATM-mediated Stabilization of ZEB1 Promotes DNA Damage Response and Radioresistance Through CHK1.

Discovery of novel ataxia telangiectasia mutated (ATM) kinase modulators: Computational simulation, biological evaluation and cancer combinational chemotherapy study

Computational Analysis of Non-synonymous SNPs in ATM Kinase: Structural Insights, Functional Implications, and Inhibitor Discovery

ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I

ATM inhibition drives metabolic adaptation via induction of macropinocytosis

Progress of ATM Inhibitors: Opportunities and Challenges

ATM and P21 Cooperate to Suppress Aneuploidy and Subsequent Tumor Development.

Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death

Phosphorylation of MAD2 at Ser195 Promotes Spindle Checkpoint Defects and Sensitizes Cancer Cells to Radiotherapy in ATM Deficient Cells

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

The Versatile Functions of ATM Kinase.

Identification of ATM Mutation As a Potential Prognostic Biomarker for Immune Checkpoint Inhibitors Therapy

Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.